Ticker Symbol: ASBIF

ASIT biotech SA

Exchange: US OTC Country: BE Currency: USD Asset Type: Common Stock

Company Profile

ASIT BioTech SA is a clinical stage biopharmaceutical company, which engages in the research and development of immunotherapy treatments for environmental and food allergies. Its products include hdm-ASIT+, for the treatment of house dust mite allergy; and pnt-ASIT+for the treatment of peanut allergy. The company was founded by Thierry Legon in May 1997 and is headquartered in Liege, Belgium.

Sector: Health Technology

Industry: Biotechnology

Standard Industrial Classification Code (SIC code): 2836

Address: 7 Rue des Chasseurs Ardennais

Website: http://www.asitbiotech.com

CEO: Michel Baijot

Tags:

Health Technology
Biotechnology

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: - - -

Beta: -

52wk. High: -

52wk. Low: -

Ytd. Change 0.00%

50 Day Moving Average: -

200 Day Moving Average: -

Shares Outstanding: 21892592

Valuation

Market Cap: -

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A